GOGOA MOBILITY ROBOTS SL

Their core work

GOGOA designs and develops wearable robotic exoskeletons for medical rehabilitation, targeting patients recovering from neurological injuries and orthopedic conditions. Their devices are worn on the body and assist or restore movement in patients with conditions like acquired brain damage, spinal cord injury, or knee damage. Beyond passive mechanical support, they have expanded into active rehabilitation technology by integrating Functional Electrical Stimulation (FES) — electrically stimulating muscles in coordination with the exoskeleton to retrain movement patterns. As a product-oriented SME from the Basque Country, they move research prototypes through full innovation cycles toward market-ready medical devices.

What they specialise in

How they've shifted over time

GOGOA began with a broad neurological scope — HANK (2016) addressed some of the most complex rehabilitation cases: acquired brain damage and spinal cord injury, conditions that require full lower-body exoskeleton support. By 2018, they shifted focus toward a more targeted, commercially viable product with BELK: a knee-specific exoskeleton that added Functional Electrical Stimulation, signaling deeper integration of neurostimulation with mechanical robotics. This trajectory suggests a deliberate move from broad neurological rehabilitation toward modular, joint-specific devices that are easier to manufacture, certify, and sell — a classic SME market-entry strategy of narrowing scope to accelerate commercialization.

GOGOA is moving toward modular, body-part-specific rehabilitation devices that combine mechanical support with active neuromuscular stimulation — a direction that aligns well with clinical demand for affordable, targeted rehab technology.

How they like to work

GOGOA exclusively coordinates their projects — they have never appeared as a mere participant, which signals a company that drives its own product agenda rather than serving as a subcontractor. Their consortia are small (3 unique partners across 3 countries), typical of SME Phase 2 projects where the company is the commercial center and partners provide clinical validation or technology components. This suggests they are a focused, self-directed partner who leads the work plan; collaborators should expect to serve a supporting role rather than co-lead.

GOGOA has worked with only 3 unique partners across 3 countries — an unusually small network consistent with focused product-development projects rather than broad research consortia. Their partnerships are likely with clinical institutions and component suppliers rather than large research organizations.

What sets them apart

GOGOA is one of very few Spanish SMEs that has twice secured EU Innovation Action funding as the lead company for physical rehabilitation exoskeletons — a niche that sits at the crossroads of robotics, medical devices, and neuroscience. Based in the Basque Country, a region with strong industrial robotics manufacturing capabilities, they combine engineering depth with a clear commercial orientation. For a consortium builder, they offer something rare: a small company that actually builds and owns the hardware, has navigated EU funding as coordinator twice, and has demonstrated the ability to take a rehabilitation device from concept to an SME Phase 2 business case.

Highlights from their portfolio

• BELK
  Funded under the highly competitive SME Phase 2 instrument with over €1M in EC support, BELK is the most commercially advanced of GOGOA's projects — combining a wearable knee exoskeleton with Functional Electrical Stimulation, positioning it as a product close to clinical deployment.
• HANK
  GOGOA's first EU-coordinated project tackled one of the hardest rehabilitation challenges — acquired brain damage and spinal cord injury — establishing their credentials in complex neurological rehabilitation robotics from the start.